We believe that people living with society’s most
challenging diseases deserve trusted medical
solutions that deliver high-quality care, wellness
and cures to live healthier, happier lives.
AngioDynamics, Inc. (NASDAQ: ANGO) is a leading provider of minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease, and oncology.
The Company and its employees understand and accept the important responsibility that its products have in a patient’s care and adhere to the highest standards of quality and compliance.
In October 2019, AngioDynamics acquired Eximo Medical, Ltd., an early commercial stage, medical device company, and its proprietary 355nm wavelength laser-technology platform. Eximo’s laser technology, which received 510(k) clearance for use in the treatment of Peripheral Artery Disease (PAD), added to AngioDynamics’ leading thrombus management and venous insufficiency technology portfolio.
Led by President and Chief Executive Officer Jim Clemmer, AngioDynamics has employees operating at locations in the United States, Canada, Europe, Asia, Latin America, and Israel, and currently reaches more than 50 markets via direct sales and distributors.
AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products.
Since its founding on February 9, 1988 as a division of E-Z-EM, AngioDynamics’ continuous focus on the development of innovative medical devices to address unmet patient needs, and its support of the medical community’s mission to deliver improved patient outcomes, has earned it the trust of the health care professionals around the world.
For more information, visit www.angiodynamics.com.